Fundraising FoxBiocartis
Mechelen, BE · 4 known investors
Find your way into Biocartis
Biocartis develops molecular diagnostic testing systems for cancer, with a focus on enabling personalized medicine through rapid, in-house biomarker analysis. The company's Idylla Platform automates molecular testing to help clinicians and patients access treatment information quickly.
Investors · 4
Advent Life Scienceslisted by Advent Life SciencesLondon
How we know: Advent Life Sciences's portfolio page · Not right? Tell us
New Rhein Healthcare Investors, LLClisted by New Rhein Healthcare Investors, LLCPhiladelphia
How we know: New Rhein Healthcare Investors, LLC's portfolio page · Not right? Tell us
PMVlisted by PMVBrussels
How we know: PMV's portfolio page · funding news · Not right? Tell us
In the news
Frequently asked questions
- What does Biocartis do?
- Biocartis develops molecular diagnostic testing systems for cancer, with a focus on enabling personalized medicine through rapid, in-house biomarker analysis. The company's Idylla Platform automates molecular testing to help clinicians and patients access treatment information quickly.
- Who are Biocartis's investors?
- Biocartis's investors include Advent Life Sciences, Korys, New Rhein Healthcare Investors, LLC, PMV.
- Where is Biocartis headquartered?
- Biocartis is headquartered in Mechelen, BE.